天然のタンパク質からアミロイドの迅速な生成<em>インビトロ</em

Summary

Proteins can either adopt a native structure or misfold into insoluble amyloid. Conditions that favor the misfolding pathway lead to the formation of different types of amyloid fibrils. The methods described here allow rapid conversion of native proteins into amyloid in vitro.

Abstract

タンパク質は、それらの特異的な三次元フォールドの誘発機能を発揮することによって生物で重要なタスクを実行する。ポリペプチドの天然の構造は、多くの目的を果たすが、それは現在ほとんどのタンパク質は、β-シートリッチアミロイドの代替的なアセンブリを採用することができることが認識される。不溶性のアミロイド線維は、最初は複数のヒトの病気と関連しているが、それらは、ますます様々な重要な細胞プロセスに関与する官能選手として表示されます。加えて、患者の組織において沈着したアミロイドは、そのような核酸およびグリコサミノグリカン（GAG）のような非タンパク質性成分を含む。これらの補因子は、不溶性沈殿物の異なるタイプの生成をもたらす、アミロイドの形成を容易にすることができる。タンパク質は、可溶性アミロイド前駆体の中間段階を介して誤って折り畳ま方法我々の理解を活用することにより、我々は、in vitroでアミロイド原繊維への天然タンパク質に変換する方法を考案した</EM>。このアプローチは、一つは、大量のアミロ​​イドの準備特定のタンパク質から生成されるアミロイドのプロパティを調べ、変換に伴う構造変化を評価することができます。

Introduction

Proteins are the most abundant biological macromolecules present in all types of cells. They occur in a great variety of sizes, structures, and post-translational modifications, and fulfill an enormous range of important biological functions when in their native forms. More than two dozens of aberrant polypeptides have been implicated in numerous human pathological conditions, such as Alzheimer's disease, Parkinson disease,  and Type 2 Diabetes^1-4. The terminal misfolded proteins accumulate as amyloid fibrils the insoluble stable aggregates that occur extracellularly or intracellularly.

Despite the implication of specific proteins in certain diseases, increasing evidence supports the notion that all polypeptides have intrinsic properties that enable amyloid transformation. A genome-wide sequence survey identified the “amylome”, by which amyloid-prone fragments constitute roughly 15% of all coding peptide segments from E. coli to humans⁵. Accordingly, an increasing number of functional amyloids, which participate in various important cellular processes, have been discovered in recent years. For example, bacteria assemble amyloids to form biofilm and spore structures that are critical for their survival and pathogenesis^6-9. Peptide hormones form amyloid deposits during storage within mammalian secretory granules before being released, further implying that the protein amyloid form can serve beneficial biological functions^6,10,11. Moreover, proteins can also assemble into amyloid fibrils to relay critical cellular signals^12,13.

For many years, the most studied amyloids are prepared from individual peptides that are associated with human diseases, such as amyloid beta or prion peptide. These peptides usually lack well defined structure and spontaneously form amyloid in solution over time, a process mediated by a partially misfolded intermediate that serves as the precursor of insoluble amyloid. The precursor of amyloid is also called soluble protein oligomer, which is rare and unstable when generated from natural peptides^14,15. However, as described earlier, almost any protein in principle can adopt amyloid conformation under the appropriate conditions. We recently established a method to prepare stabilized soluble oligomers of native proteins, which readily form amyloid in the presence of various cofactors¹⁶. The resulting amyloid fibrils reflect the complex nature of the terminal protein misfolding aggregates^17,18. Here we use the term protein-only amyloid to refer the protein fibrils without cofactors and hybrid amyloid for the fibrils containing nonproteinaceous components.

Previously, various methods have been developed to generate amyloid in vitro by applying conditions known to favor protein misfolding, such as high temperature, hydrophobic environment, and pH variations^19-23. However, they associate with various problems, such as low efficiency, reversible folding, large batch variations or slow kinetics. The approach described here is reproducible, easy to scale up, and allows one to precisely control the timing and condition of amyloid conversion.

Protocol

1. Prepare MES Buffer Use MES buffer (0.1 M 2-(N-morpholino)ethanesulfonic acid and 0.9 M NaCl) to prepare both protein-only amyloid as well as stabilized soluble protein oligomers. Weigh 1.95 g of MES and 5.27 g of NaCl. Add H2O and adjust pH to 4.7. Make up the final volume to 100 ml. Store at 4º C for up to 6 months. 2. Prepare Protein-only Amyloid Directly from Native Proteins Weigh protein of choice (any native protein or peptide) and reconst…

Representative Results

The ability to convert native proteins directly to amyloid relies on the conformational change incurred at high temperature in the MES buffer. Precipitation in the solution is a good indication of protein aggregation and possibly amyloid formation. On the other hand, to allow soluble protein oligomer to stabilize, EDC is used to crosslink the proteins to solidify the oligomeric conformation induced in MES buffer. As a result, the stabilized protein oligomers are multimeric proteins (Figure 1), distinct f…

Discussion

The method described here offers a rapid and flexible means to prepare amyloid fibrils in vitro from virtually any protein or peptide of choice. Several different types of amyloid can be reliably prepared – protein-only fibrils or hybrid aggregates containing DNA, RNA,  or glycosaminoglycans. The procedures involved are simple, straight forward, and do not require advanced technical training. The amyloid prepared by this method is quite stable and can be safely stored at 4 ºC or frozen at -80 ºC f…

Materials

2-(N-morpholino)ethanesulfonic acid (MES)	Sigma-Aldrich	M8250
NaCl	Fisher	BP358-10
1-ethyl-3-[3-dimethyl-aminopropyl] carbodiimide hydrochloride (EDC)	Thermo/Pierce	22980
DNA from salmon sperm	Sigma	D1626
RNA from torula yeast	Sigma	R6625
Heparin from porcine intestinal mucosa	Sigma	H3149
Tris base	Fisher	BP152-1
Equipment:
Material Name	Company	Catalogue Number
Water bath	Fisher Science	Isotemp 210
Slide-A-Lyzer dialysis cassette	Thermo/Pierce	66380